CHE
Chemed Corporation · Healthcare · Medical - Care Facilities
Momentum inputs (comparable managers):
holder breadth +5.0% ·
share flow +1.4% ·
net new positions +4.8%
· formula
Broad accumulation: rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | +1 | 53.78K | $26.72M | +1 | −1 |
| Q2 2026 | 131 | +6 | 8.89M | $4.13B | +9 | −4 |
| Q1 2026 | 129 | 0 | 8.71M | $3.29B | +5 | −6 |
| Q4 2025 | 129 | -2 | 9.90M | $4.23B | +1 | −2 |
| Q3 2025 | 22 | -1 | 5.87M | $2.63B | n/a | −2 |
| Q2 2025 | 21 | +1 | 4.75M | $2.31B | +2 | −1 |
| Q1 2025 | 17 | 0 | 1.55M | $954.33M | +1 | −1 |
| Q4 2024 | 17 | +1 | 1.54M | $817.61M | +2 | −1 |
| Q3 2024 | 15 | 0 | 874.91K | $525.85M | n/a | n/a |
| Q2 2024 | 15 | n/a | 976.21K | $529.86M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passive) | 1.60M | n/a | $780.34M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 2 | BlackRock ✦ (passive) | 1.34M | n/a | $651.94M | 0.0% | n/c | 1 | SEC ↗ ×18 |
| 3 | State Street Global Advisors ✦ (passive) | 477.01K | -1.7% | $232.27M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passive) | 355.81K | -0.1% | $173.27M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 5 | AQR Capital Management ✦ | 201.04K | +160.9% | $97.89M | 0.1% | ▲ Add | 5 | SEC ↗ ×5 |
| 6 | Fidelity (FMR) ✦ | 188.82K | n/a | $91.94M | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 7 | Norges Bank ✦ (passive) | 183.57K | -8.6% | $89.39M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 8 | Millennium Management ✦ | 134.78K | +87.5% | $65.63M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 9 | Renaissance Technologies ✦ | 88.50K | +73.2% | $43.09M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 10 | D. E. Shaw & Co. ✦ | 40.13K | -8.1% | $19.54M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 11 | Two Sigma Investments ✦ | 36.03K | +869.3% | $17.54M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 12 | T. Rowe Price ✦ | 21.24K | -6.9% | $10.34M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 13 | GAMCO Investors ✦ | 20.28K | +1.9% | $9.87M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 14 | Citadel Advisors ✦ | 16.74K | -65.3% | $8.15M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 15 | Arrowstreet Capital ✦ | 11.37K | +67.0% | $5.53M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 16 | Gotham Asset Management ✦ | 10.20K | -31.8% | $4.97M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 17 | Fisher Asset Management ✦ | 9.76K | -15.0% | $4.75M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 18 | Adage Capital Partners ✦ | 4.50K | New | $2.19M | 0.0% | New | 1 | SEC ↗ |
| 19 | Bridgewater Associates ✦ | 2.84K | -63.0% | $1.38M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 20 | Wellington Management ✦ | 1.97K | -2.3% | $957,791 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 21 | Marshall Wace ✦ | 1.19K | New | $579,448 | 0.0% | New | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Adage Capital Partners | $2.19M | 0.0% |
| Marshall Wace | $579,448 | 0.0% |
Exited
| Point72 Asset Management | $79.18M | was 0.2% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 486 holders, 12.67M shares, $4.47B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer, Director · 2.00K sh · $1.03M
Officer, Director · 2.00K sh · $1.00M
Officer, Director · 2.00K sh · $1.08M
Officer · 1.00K sh · $541,040
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology